A new study conducted at the U.S. National Cancer Institute's Centre for Cancer Research indicates that the combination of MRI with ultrasound in prostate biopsies is better able to diagnose 30% more high-risk cancers compared to standard biopsies alone. According to senior author Dr. Peter Pinto, the MRI-targeted biopsy "finds the aggressive tutors that need to be treated but also not finding those small microscopic low-grade tutors that are not clinically important but lead to over treatment."
Click here to learn more about this study, recently published in the Journal of the American Medical Association.
No comments:
Post a Comment